Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.41 |
| ▸ | HRH1 | P35367 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1809358 | 0.81 | CHRM3 (0.55) | CHRM2CHRM1MAPTCHRM5CHRM3 | |
| SCHEMBL1809355 | 0.81 | CHRM3 (0.55) | CHRM2CHRM1MAPTCHRM5CHRM3 | |
| SCHEMBL1783715 | 0.77 | CHRM2 (0.56) | PTGER1CHRM2CHRM1MAPTCHRM5 | |
| SCHEMBL723428 | 0.77 | CHRM2 (0.56) | PTGER1CHRM2CHRM1MAPTCHRM5 | |
| Hydrochloric Acid SCHEMBL597394 | 0.77 | CHRM2 (0.55) | PTGER1CHRM2CHRM1MAPTCHRM5 | |
| Hydrochloric Acid SCHEMBL597393 | 0.77 | CHRM2 (0.55) | PTGER1CHRM2CHRM1MAPTCHRM5 | |
| SCHEMBL5179157 | 0.74 | CHRM2 (0.55) | CHRM2CHRM1MAPTSMN1; SMN2CHRM5 | |
| SCHEMBL5179164 | 0.74 | CHRM2 (0.55) | CHRM2CHRM1MAPTSMN1; SMN2CHRM5 | |
| SCHEMBL14830850 | 0.74 | LMNA (0.49) | CHRM2CHRM1MAPTL3MBTL1TDP1 | |
| SCHEMBL15459396 | 0.74 | CHRM2 (0.62) | PTGER1CHRM2CHRM1MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110124903-A1 | SOLID STATE FORMS OF FESOTERODINE INTERMEDIATES | ACTAVIS GROUP PTC EHF (IS) | 2011-05-26 | — | — | US | claimed |
| US-20110124903-A1 | SOLID STATE FORMS OF FESOTERODINE INTERMEDIATES | ACTAVIS GROUP PTC EHF (IS) | 2011-05-26 | — | — | US | disclosed |
| US-20100217034-A1 | Process for the Preparation of Fesoterodine | ACTAVIS GROUP PTC EHF (IS) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100217034-A1 | Process for the Preparation of Fesoterodine | ADRB3, FES, QDPR | PTGER1 3853/4885CHRM2 107/4885CHRM1 279/4885 |
| US-20110124903-A1 | SOLID STATE FORMS OF FESOTERODINE INTERMEDIATES | FES, NISCH, RPS27A | PTGER1 2625/4885CHRM2 530/4885CHRM1 646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.